Likewise, trametinib 78 is a dual kinase inhibitor used to induce the pyroptotic pathways in pancreatic cancer and melanoma through caspase-1/GSDMD activation [42, 194, 195] (Fig. 13). Here, CASP1 is linked to melanoma.